Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 8, Supplement B, 1981   [Index by Author] 


Down Preface
Down List of Participants
Down Articles
Down Errata
Down Articles
Down Indexes


[Search ALL Issues]


Front Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Preface Back

J. D. Williams and M. W. Casewell
Preface
J. Antimicrob. Chemother. 1981 8: iii-iv; doi:10.1093/jac/8.suppl_B.iii [PDF] [Request Permissions]  

List of Participants Back

List Of Participants
J. Antimicrob. Chemother. 1981 8: v-ix; doi:10.1093/jac/8.suppl_B.v [PDF] [Request Permissions]  

Articles Back

P. W. Muggleton
Why ceftazidime?
J. Antimicrob. Chemother. 1981 8: 1-3; doi:10.1093/jac/8.suppl_B.1 [PDF] [Request Permissions]  

P. B. Harper
The in-vitro properties of ceftazidime
J. Antimicrob. Chemother. 1981 8: 5-13; doi:10.1093/jac/8.suppl_B.5 [Abstract] [PDF] [Request Permissions]  

W. Brumfitt and J. M. T. Hamilton-Miller
The susceptibility of nosocomial pathogens to ceftazidime
J. Antimicrob. Chemother. 1981 8: 15-21; doi:10.1093/jac/8.suppl_B.15 [Abstract] [PDF] [Request Permissions]  

Ian Phillips, Christine Warren, Kevin Shannon, Anna King, and David Hanslo
Ceftazidime: in-vitro antibacterial activity and susceptibility to β-lactamases compared with that of cefotaxime, moxalactam and other β-lactam antibiotics
J. Antimicrob. Chemother. 1981 8: 23-31; doi:10.1093/jac/8.suppl_B.23 [Abstract] [PDF] [Request Permissions]  

H. Knothe and G. A. Dette
The in-vitro activity of ceftazidime against clinically important pathogens
J. Antimicrob. Chemother. 1981 8: 33-41; doi:10.1093/jac/8.suppl_B.33 [Abstract] [PDF] [Request Permissions]  

Anne M. Harris, S. J. Plested, and P. B. Harper
A comparison of the in-vitro properties of ceftazidime with those of new broad-spectrum cephalosporins and gentamicin
J. Antimicrob. Chemother. 1981 8: 43-45; doi:10.1093/jac/8.suppl_B.43 [PDF] [Request Permissions]  

A. J. Bint, P. Yeoman, P. Kilburn, R. Anderson, and E. Stansfield
The in-vitro activity of ceftazidime compared with that of other cephalosporins
J. Antimicrob. Chemother. 1981 8: 47-51; doi:10.1093/jac/8.suppl_B.47 [Abstract] [PDF] [Request Permissions]  

Ian D. Wilkinson and Layne O. Gentry
In-vitro comparison of ceftazidime and nine other antimicrobial agents against hospital strains of Gram-negative bacteria
J. Antimicrob. Chemother. 1981 8: 53-56; doi:10.1093/jac/8.suppl_B.53 [Abstract] [PDF] [Request Permissions]  

A. M. Clarke and S. J. V. Zemcov
In-vitro activity of ceftazidime compared with other β-lactam antibiotics
J. Antimicrob. Chemother. 1981 8: 57-62; doi:10.1093/jac/8.suppl_B.57 [Abstract] [PDF] [Request Permissions]  

R. Vanhoof, B. Gordts, H. Coignau, G. Stas, and J. P. Butzler
The in-vitro activity of ceftazidime: comparison with other β-lactam antibiotics
J. Antimicrob. Chemother. 1981 8: 63-66; doi:10.1093/jac/8.suppl_B.63 [Abstract] [PDF] [Request Permissions]  

Ludo Verbist and Jan Verhaegen
Ceftazidime: comparative in-vitro study
J. Antimicrob. Chemother. 1981 8: 67-71; doi:10.1093/jac/8.suppl_B.67 [Abstract] [PDF] [Request Permissions]  

H. Giamarellou, A. Avlami, V. Matsakas, J. Kosmidis, and G. K. Daikos
In-vitro studies with ceftazidime
J. Antimicrob. Chemother. 1981 8: 73-77; doi:10.1093/jac/8.suppl_B.73 [Abstract] [PDF] [Request Permissions]  

H. H. Schassan and J. Fedder
Activity of ceftazidime and newer antibiotics against Gram-negative bacilli
J. Antimicrob. Chemother. 1981 8: 79-82; doi:10.1093/jac/8.suppl_B.79 [Abstract] [PDF] [Request Permissions]  

G. Acuna, J. Johnston, L. S. Young, and W. J. Martin
In-vitro studies with ceftazidime against aerobic Gram-negative bacilli and Bacteroides fragilis group
J. Antimicrob. Chemother. 1981 8: 83-89; doi:10.1093/jac/8.suppl_B.83 [Abstract] [PDF] [Request Permissions]  

Anthony W. Chow and Karen H. Bartlett
Comparative in-vitro activity of ceftazidime (GR-20263) and other β-lactamase stable cephalosporins against anaerobic bacteria
J. Antimicrob. Chemother. 1981 8: 91-95; doi:10.1093/jac/8.suppl_B.91 [Abstract] [PDF] [Request Permissions]  

B. Van Klingeren
An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa
J. Antimicrob. Chemother. 1981 8: 97-105; doi:10.1093/jac/8.suppl_B.97 [Abstract] [PDF] [Request Permissions]  

D. A. Leigh and D. Nisbet
Antibacterial activity of ceftazidime (GR 20263) against routine hospital isolates and highly resistant strains of Enterobacteriaceae and Pseudomonas aeruginosa
J. Antimicrob. Chemother. 1981 8: 107-110; doi:10.1093/jac/8.suppl_B.107 [Abstract] [PDF] [Request Permissions]  

A. Bauernfeind
An evaluation of the activity of cephalosporins against Pseudomonas aeruginosa
J. Antimicrob. Chemother. 1981 8: 111-117; doi:10.1093/jac/8.suppl_B.111 [Abstract] [PDF] [Request Permissions]  

A. Philippon, G. Paul, and P. Nevot
Comparative in-vitro activity of cefsulodin and ceftazidime against ticarcillin-resistant Pseudomonas aeruginosa
J. Antimicrob. Chemother. 1981 8: 119-122; doi:10.1093/jac/8.suppl_B.119 [Abstract] [PDF] [Request Permissions]  

A. Thabaut, J.-L. Durosoir, and P. Saliou
Comparison of the in-vitro activities of ceftazidime and new cephalosporins against 107 strains of Pseudomonas aeruginosa and 249 strains of cefazolin-resistant Enterobacteriaceae
J. Antimicrob. Chemother. 1981 8: 123-125; doi:10.1093/jac/8.suppl_B.123 [Abstract] [PDF] [Request Permissions]  

E. Yourassowsky, M. P. Van der Linden, M. L. Lismont, and F. Crokaert
Growth curves of Escherichia coli and Pseudomonas aeruginosa submitted to different ceftazidime concentrations
J. Antimicrob. Chemother. 1981 8: 127-130; doi:10.1093/jac/8.suppl_B.127 [Abstract] [PDF] [Request Permissions]  

Harold C. Neu
In-vitro activity of ceftazidime, a β-lactamase stable cephalosporin
J. Antimicrob. Chemother. 1981 8: 131-134; doi:10.1093/jac/8.suppl_B.131 [Abstract] [PDF] [Request Permissions]  

Pramod M. Shah
Bactericidal activity of ceftazidime against Pseudomonas aeruginosa under conditions simulating serum pharmacokinetic
J. Antimicrob. Chemother. 1981 8: 135-140; doi:10.1093/jac/8.suppl_B.135 [Abstract] [PDF] [Request Permissions]  

R. Labia, R. Beguin-Billecoq, and M. Guionie
Behaviour of ceftazidime towards β-lactamases
J. Antimicrob. Chemother. 1981 8: 141-146; doi:10.1093/jac/8.suppl_B.141 [Abstract] [PDF] [Request Permissions]  

R. P. Mouton, G. P. A. Bongaerts, and M. H. van Gestel
Susceptibility of ceftazidime and other cephalosporins to a range of β-lactamases and their potential as inducing agents
J. Antimicrob. Chemother. 1981 8: 147-152; doi:10.1093/jac/8.suppl_B.147 [Abstract] [PDF] [Request Permissions]  

Lars Adamsson, Kathrine Dornbusch, and Hans O. Hallander
Influence of bacterial β-lactamase production on susceptibility in agar or broth to new cephalosporins
J. Antimicrob. Chemother. 1981 8: 153-162; doi:10.1093/jac/8.suppl_B.153 [Abstract] [PDF] [Request Permissions]  

D. M. Livermore, Rosamund J. Williams, and J. D. Williams
In-vitro activity of ceftazidime against Pseudomonas aeruginosa: and its stability to pseudomonal β-lactamases
J. Antimicrob. Chemother. 1981 8: 163-167; doi:10.1093/jac/8.suppl_B.163 [Abstract] [PDF] [Request Permissions]  

P. C. Fleming and Brenda Knie
Activity of ceftazidime against Pseudomonas aeruginosa from bacteraemic and fibrocystic patients
J. Antimicrob. Chemother. 1981 8: 169-173; doi:10.1093/jac/8.suppl_B.169 [Abstract] [PDF] [Request Permissions]  

Niamh Kelly, F. R. Falkiner, C. T. Keane, M. Murphy, and M. X. Fitzgerald
The in-vitro activity of three anti-pseudomonal cephalosporins against isolates from patients with cystic fibrosis
J. Antimicrob. Chemother. 1981 8: 175-178; doi:10.1093/jac/8.suppl_B.175 [Abstract] [PDF] [Request Permissions]  

John D. Nelson and Sharon Shelton
Activity of ceftazidime against Gram-negative bacilli from paediatric patients
J. Antimicrob. Chemother. 1981 8: 179-181; doi:10.1093/jac/8.suppl_B.179 [Abstract] [PDF] [Request Permissions]  

Arne Forsgren
The immunosuppressive effect of cephalosporins and cephalosporin-gentamicin combinations
J. Antimicrob. Chemother. 1981 8: 183-186; doi:10.1093/jac/8.suppl_B.183 [Abstract] [PDF] [Request Permissions]  

Ronald N. Jones, Arthur L. Barry, Clyde Thornsberry, E. Hugh Gerlach, Peter C. Fuchs, Thomas L. Gavan, and Herbert M. Sommers
Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests
J. Antimicrob. Chemother. 1981 8: 187-211; doi:10.1093/jac/8.suppl_B.187 [Abstract] [PDF] [Request Permissions]  

H. Grimm
Bacteriological investigations with ceftazidime in vitro
J. Antimicrob. Chemother. 1981 8: 213-216; doi:10.1093/jac/8.suppl_B.213 [PDF] [Request Permissions]  

R. Crosse, Doreen G. Burt, and Monica J. Gardner
Ceftazidime susceptibility testing—disc loading
J. Antimicrob. Chemother. 1981 8: 217-219; doi:10.1093/jac/8.suppl_B.217 [PDF] [Request Permissions]  

R. Crosse, Doreen G. Burt, and Monica J. Gardner
Ceftazidime regression studies
J. Antimicrob. Chemother. 1981 8: 221-223; doi:10.1093/jac/8.suppl_B.221 [PDF] [Request Permissions]  

J. E. Thornton
The microbiological assay of ceftazidime
J. Antimicrob. Chemother. 1981 8: 225-226; doi:10.1093/jac/8.suppl_B.225 [PDF] [Request Permissions]  

J. Ayrton
Assay of ceftazidime in biological fluids using high-pressure liquid chromatography
J. Antimicrob. Chemother. 1981 8: 227-231; doi:10.1093/jac/8.suppl_B.227 [Abstract] [PDF] [Request Permissions]  

Betty L. Richardson, J. D. Woodford, and G. D. Andrews
The pharmacy of ceftazidime
J. Antimicrob. Chemother. 1981 8: 233-236; doi:10.1093/jac/8.suppl_B.233 [Abstract] [PDF] [Request Permissions]  

K. Capel-Edwards, C. R. Losty, M. L. Tucker, and D. A. H. Pratt
Pre-clinical safety evaluation of ceftazidime
J. Antimicrob. Chemother. 1981 8: 237-239; doi:10.1093/jac/8.suppl_B.237 [PDF] [Request Permissions]  

K. Capel-Edwards and D. A. H. Pratt
Renal tolerance of ceftazidime in animals
J. Antimicrob. Chemother. 1981 8: 241-245; doi:10.1093/jac/8.suppl_B.241 [PDF] [Request Permissions]  

P. Acred, D. M. Ryan, M. A. Sowa, and Christine M. Watts
The in-vivo antibacterial activity of ceftazidime (Gr 20263)—a comparison with other new β-lactam antibiotics and gentamicin
J. Antimicrob. Chemother. 1981 8: 247-255; doi:10.1093/jac/8.suppl_B.247 [Abstract] [PDF] [Request Permissions]  

W. Ritzerfeld
Ceftazidime activity in experimental pseudomonas pyelonephritis in rats
J. Antimicrob. Chemother. 1981 8: 257-259; doi:10.1093/jac/8.suppl_B.257 [Abstract] [PDF] [Request Permissions]  

S. M. Harding, J. Ayrton, J. E. Thornton, A. J. Munro, and M. I. J. Hogg
Pharmacokinetics of ceftazidime in normal subjects
J. Antimicrob. Chemother. 1981 8: 261; doi:10.1093/jac/8.suppl_B.261 [PDF] [Request Permissions]  

S. M. Harding, A. J. Monro, J. E. Thornton, J. Ayrton, and M. I. J. Hogg
The comparative pharmacokinetics of ceftazidime and cefotaxime in healthy volunteers
J. Antimicrob. Chemother. 1981 8: 263-272; doi:10.1093/jac/8.suppl_B.263 [Abstract] [PDF] [Request Permissions]  

Ruedi Lüthy, Jürg Blaser, Antonio Bonetti, Hanspeter Simmen, Richard Wise, and Walter Siegenthaler
Human pharmacokinetics of ceftazidime in comparison to moxalactam and cefotaxime—abstract
J. Antimicrob. Chemother. 1981 8: 273-276; doi:10.1093/jac/8.suppl_B.273 [PDF] [Request Permissions]  

R. Wise, G. C. Armstrong, R. M. Brown, and J. M. Andrews
The pharmacokinetics and tissue penetration of ceftazidime and cefamandole in healthy volunteers
J. Antimicrob. Chemother. 1981 8: 277-282; doi:10.1093/jac/8.suppl_B.277 [Abstract] [PDF] [Request Permissions]  

D. M. Ryan, Ursula Mason, and S. M. Harding
The penetration of ceftazidime into extravascular fluid
J. Antimicrob. Chemother. 1981 8: 283-288; doi:10.1093/jac/8.suppl_B.283 [Abstract] [PDF] [Request Permissions]  

Björn Hoffstedt and Mats Walder
Penetration of ceftazidime into extracellular fluid in patients
J. Antimicrob. Chemother. 1981 8: 289-292; doi:10.1093/jac/8.suppl_B.289 [Abstract] [PDF] [Request Permissions]  

D. H. Wittmann, H-H. Schassan, F. Kohler, and W. Seibert
Pharmacokinetic studies of ceftazidime in serum, bone, bile, tissue fluid and peritoneal fluid
J. Antimicrob. Chemother. 1981 8: 293-297; doi:10.1093/jac/8.suppl_B.293-a [Abstract] [PDF] [Request Permissions]  

Errata Back

D. H. Wittmann, H.-H. Schassan, F. Kohler, and W. Seibert
Pharmacokinetic studies of ceftazidime in serum, bone, bile, tissue fluid and peritoneal fluid
J. Antimicrob. Chemother. 1981 8: 293; doi:10.1093/jac/8.suppl_B.293-b [Abstract] [PDF] [Request Permissions]  

Articles Back

H. Feist, N. Vetter, F. Muhar, K. J. Williams, H. J. Brandstetter, and I. Ho
Trial of ceftazidime efficacy in respiratory infections at two dose levels
J. Antimicrob. Chemother. 1981 8: 299-301; doi:10.1093/jac/8.suppl_B.299 [Abstract] [PDF] [Request Permissions]  

Tor Pettersson, Paavo Ahvonen, and Eivor Storgárds
Clinical experience in the treatment of lower respiratory tract infections with ceftazidime
J. Antimicrob. Chemother. 1981 8: 303-305; doi:10.1093/jac/8.suppl_B.303 [Abstract] [PDF] [Request Permissions]  

G. De Sandre, R. Corrocher, I, G. B. Gabrielli, and I. Ho
Clinical experience with ceftazidime for lower respiratory tract infections
J. Antimicrob. Chemother. 1981 8: 307-310; doi:10.1093/jac/8.suppl_B.307 [PDF] [Request Permissions]  

P. Zuccoli, I. Ho, M. Mergoni, and L. Melley
Evaluation of ceftazidime in the treatment of severe infection
J. Antimicrob. Chemother. 1981 8: 311-312; doi:10.1093/jac/8.suppl_B.311 [Abstract] [PDF] [Request Permissions]  

J. K. Wardle, J. B. Selkon, H. R. Ingham, and R. Freeman
Ceftazidime in Gram-negative infections: three case reports
J. Antimicrob. Chemother. 1981 8: 313-316; doi:10.1093/jac/8.suppl_B.313 [Abstract] [PDF] [Request Permissions]  

N. Clumeck, Y. Vanlaethem, B. Gordts, N. Jaspar, and J. P. Butzler
Use of ceftazidime in severe Gram-negative infections — a preliminary study
J. Antimicrob. Chemother. 1981 8: 317-321; doi:10.1093/jac/8.suppl_B.317 [Abstract] [PDF] [Request Permissions]  

W. Graninger, I. Ho, M. Francesconi, C. Schmidbauer, and T. Egger
Treatment of complicated urinary tract infection caused by Pseudomonas aeruginosa—a comparison of the efficacy of ceftazidime with that of netilmicin
J. Antimicrob. Chemother. 1981 8: 323-324; doi:10.1093/jac/8.suppl_B.323 [Abstract] [PDF] [Request Permissions]  

F. Crokaert, C. Potvliege, M. P. Vanderlinden, Y. Glupczynski, and E. Yourassowsky
Clinical and bacteriological evaluation of ceftazidime (GR 20263) as an antipseudomonal drug
J. Antimicrob. Chemother. 1981 8: 325-329; doi:10.1093/jac/8.suppl_B.325 [Abstract] [PDF] [Request Permissions]  

G. K. Daikos, J. Kosmidis, Ch. Stathakis, H. Giamarellou, E. Douzinas, S. Kastanakis, and B. Papathanassiou
Ceftazidime: therapeutic results in various infections and kinetic studies
J. Antimicrob. Chemother. 1981 8: 331-337; doi:10.1093/jac/8.suppl_B.331 [Abstract] [PDF] [Request Permissions]  

Keith Krasinski and John D. Nelson
Pharmacokinetics and efficacy of ceftazidime in experimental Haemophilus influenzae b meningitis
J. Antimicrob. Chemother. 1981 8: 339-343; doi:10.1093/jac/8.suppl_B.339 [Abstract] [PDF] [Request Permissions]  

Anthony W. Chow and Karen H. Bartlett
Comparative in-vitro activity of ceftazidime (GR 20263) and other β-lactamase stable cephalosporins against pseudomonas: Effect of inoculum size and divalent cation supplementation
J. Antimicrob. Chemother. 1981 8: 345-348; doi:10.1093/jac/8.suppl_B.345 [Abstract] [PDF] [Request Permissions]  

L. S. Young
Ceftazidime: summary of the First International Symposium
J. Antimicrob. Chemother. 1981 8: 349-352; doi:10.1093/jac/8.suppl_B.349 [PDF] [Request Permissions]  

Indexes Back

Index
J. Antimicrob. Chemother. 1981 8: 353-358; doi:10.1093/jac/8.suppl_B.353 [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.